Teva's senior notes and debentures and convertible debentures are issued by various special-purpose finance subsidiaries. All such debt is guaranteed by Teva Pharmaceutical Industries Ltd.



 Debt Factsheet

Senior Notes and Debentures

Issued
Currency
Annual
Interest
Principal Amount
Issued
Current
Outstanding
Due
Prospectuses
    (%) (U.S. $ in MM)
January 2006USD6.1501,000781January 2036
November 2011USD3.6501,7501,211November 2021
April 2012CHF1.500459465October 2018
April 2012Euro2.8751,1261,181April 2019
December 2012USD2.250700700March 2020
December 2012USD2.9501,300865December 2022
March 2015Euro1.2501,4461,526March 2023
March 2015Euro1.875779824March 2027
July 2016USD1.4001,5001,499July 2018
July 2016USD1.7002,0002,000July 2019
July 2016USD2.2003,0002,996July 2021
July 2016USD2.8003,0002,992July 2023
July 2016USD3.1503,5003,492October 2026
July 2016USD4.1002,0001,984October 2046
July 2016CHF0.125306310July 2018
July 2016CHF0.500357362July 2022
July 2016CHF1.000357362July 2025
July 2016Euro0.3751,9472,062July 2020
July 2016Euro1.1251,6691,160October 2024
July 2016Euro1.625834877October 2028



Convertible Senior Debentures

Issued
Annual interest rate
Initial Principal amount
Principal amount at 3/31/2017
Year due
Conversion price June 2017
No of Teva shares issuable upon full conversion at 3/31/2017
Earliest date of redemption at issuer's option / repurchase at holder's option
  (%) (U.S. $ in MM)   (U.S. $)(in MM) 
January 2006(1)0.25$575$5142026$39.9015See footnote 1 Issuer - on demand
Holders - on 2/1/2021

To view the prospectus supplement relating to the January 2006 debentures - click here

For conversion and other notices - click here


(1) These convertible senior debentures due 2026 include a "net share settlement" feature according to which the principal of the debentures will be paid in cash and in the case of conversion, only the residual conversion value above the principal will be paid in Teva shares.



Term Loans and Other Facilities

Source
Year
of
Facility
Currency
Annual
Interest Rate (%)
Principal Amount
Issued
Due
Additional Information
      (%) (U.S. $ in MM)  
Private Placement1998USD7.2152018

Term Loan*

2017JPY0.555202022

Term Loan*

2012JPY1.423112019

Term Loan*

2013JPYJPY Libor +0.33112018

Term Loan*

2017JPYJPY Libor +0.2252512018

Term Loan*

2016USDUSD Libor +1.1252,5002018

Term Loan*

2016USDUSD Libor +1.252,0802020

Revolving Credit Facility*

2015USDUSD Libor +1.125-N/A$4.5 b facility available for 5 years

*The following amendment document applies to the term loans and revolving credit facility noted above

 Covenant Amendments – September 2017